Genmab A/S (NASDAQ: GMAB) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Ram Selvaraju ...
Barchart on MSN
5 Under-the-Radar Biotech Stocks That Could Soar in 2026
The biotech sector has long offered investors high-risk, high-reward stocks. While large players are making headlines, the ...
Dyne Therapeutics’ stock sees record rally, but one analyst says it could still climb a lot further, after a rival got bought ...
TipRanks on MSN
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
Novartis is buying Avidity Biosciences in an all-cash deal valued at $12 billion to access Avidity's experimental treatments for neuromuscular diseases.
I agree to the Terms of Use , Privacy Notice and Cookie Notice. I agree to the Terms of Use , Privacy Notice and Cookie ...
23h
Janus Henderson, Avidity Biosciences, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday
Grupo Financiero Galicia S.A. (NASDAQ: GGAL) gained 36% to $48.15. Shares of Argentine stocks traded higher after President ...
Investing.com - Regeneron has posted third-quarter adjusted earnings per share of $11.83 on revenue of $3.75 billion, both topping Wall Street expectations. Shares of the biotechnology firm were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback